PL391676A1 - Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP) do zwalczania ludzkiego wirusa nabytego braku odporności (HIV), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna - Google Patents

Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP) do zwalczania ludzkiego wirusa nabytego braku odporności (HIV), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna

Info

Publication number
PL391676A1
PL391676A1 PL391676A PL39167610A PL391676A1 PL 391676 A1 PL391676 A1 PL 391676A1 PL 391676 A PL391676 A PL 391676A PL 39167610 A PL39167610 A PL 39167610A PL 391676 A1 PL391676 A1 PL 391676A1
Authority
PL
Poland
Prior art keywords
fltmp
fluorothymidine
monophosphate
analogues
hiv
Prior art date
Application number
PL391676A
Other languages
English (en)
Other versions
PL218333B1 (pl
Inventor
Agnieszka Miazga
Przemysław Ziemkowski
Tadeusz Kulikowski
Francois Hamy
Severine Louvel
Thomas Klimkait
Original Assignee
Instytut Biochemii I Biofizyki, Polska Akademia Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki, Polska Akademia Nauk filed Critical Instytut Biochemii I Biofizyki, Polska Akademia Nauk
Priority to PL391676A priority Critical patent/PL218333B1/pl
Priority to EP10172852.5A priority patent/EP2402357B1/en
Publication of PL391676A1 publication Critical patent/PL391676A1/pl
Publication of PL218333B1 publication Critical patent/PL218333B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia są analogi 5'-monofosforanu 3'-fluorotymidyny (FLTMP) do zwalczania ludzkiego wirusa nabytego braku odporności (HIV), przedstawione wzorem 1, w którym X i Y są takie same lub różne i oznaczają niezależnie, atom siarki lub atom tlenu, przy czym co najmniej jedno z tych oznaczeń oznacza atom siarki, a R są takie same lub różne i oznaczają kation wybrany z grupy obejmującej Li+, Na+, K+ lub grupę N+(CH2CH3)3.
PL391676A 2010-06-30 2010-06-30 Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna PL218333B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL391676A PL218333B1 (pl) 2010-06-30 2010-06-30 Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna
EP10172852.5A EP2402357B1 (en) 2010-06-30 2010-08-15 Analogs of 2',3'-dideoxy-3'-fluorothymidine 5'-monophosphate (FLTMP) for use in the treatment of infections caused by human HIV-1 strains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL391676A PL218333B1 (pl) 2010-06-30 2010-06-30 Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna

Publications (2)

Publication Number Publication Date
PL391676A1 true PL391676A1 (pl) 2012-01-02
PL218333B1 PL218333B1 (pl) 2014-11-28

Family

ID=43638844

Family Applications (1)

Application Number Title Priority Date Filing Date
PL391676A PL218333B1 (pl) 2010-06-30 2010-06-30 Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna

Country Status (2)

Country Link
EP (1) EP2402357B1 (pl)
PL (1) PL218333B1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL197669B1 (pl) * 2002-02-28 2008-04-30 Pan Inst Biochemii I Biofizyki Nowe analogi 2',3'-dideoksy-3'-fluorotymidyny o aktywności przeciwko wirusom (54) ludzkiego niedoboru immunologicznego HIV-1 i HIV-2, sposób ich wytwarzania oraz zawierające je środki farmaceutyczne

Also Published As

Publication number Publication date
EP2402357A1 (en) 2012-01-04
EP2402357B1 (en) 2015-10-14
PL218333B1 (pl) 2014-11-28

Similar Documents

Publication Publication Date Title
PH12012502284A1 (en) Antiviral nucleoside analogs
ECSP17084267A (es) Pirazolo[1,5—a]pirimidinas como agentes antivirales
PH12016500389B1 (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
TR201905009T4 (tr) Polisiklik-karbamoilpiridon bileşikleri ve bunların farmasötik kullanımları.
EA030189B8 (ru) Аналоги 2'-хлоронуклеозидов для инфекции вгс
WO2016096174A8 (en) Cyclic dinucleotides for cytokine induction
EA201000614A1 (ru) Производные пурина как лиганды аденозинового рецептора а
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
TN2015000121A1 (en) Gdf-8 inhibitors
RS54123B1 (en) THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE
IN2014CN00712A (pl)
EA201490489A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
TW200736234A (en) Chemical compounds
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
GEP201606555B (en) Compounds and compositions for modulating egfr activity
CR20150313A (es) Composiciones farmacéuticas
MX350810B (es) Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc.
SE0302192D0 (sv) Novel compounds
MX2009004906A (es) Sulfonamidas heterociclicas que tienen actividad antagonistica del edg-1.
CA2862755A1 (en) Antiviral compounds with a dibenzooxaheterocycle moiety
BR112018002115A2 (pt) benzamidas aneladas
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
CY1126071T1 (el) Φαρμακευτικα σκευασματα αναλογων κυκλοσπορινης
EA202090978A1 (ru) Новые макроциклические производные, способ их получения и содержащие их фармацевтические композиции
PL391676A1 (pl) Analogi 5'-monofosforanu 2',3'-dideoksy-3'-fluorotymidyny (FLTMP) do zwalczania ludzkiego wirusa nabytego braku odporności (HIV), ich zastosowanie oraz farmaceutycznie dopuszczalna forma farmaceutyczna